TickerFacts.

A business in context

RVMD research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-31 · 0001193125-26-380277

  2. 8-K · Current report

    Report date 2026-08-27 · 0001193125-26-377362 · Items 1.01,2.03

  3. 8-K · Current report

    Report date 2026-08-26 · 0001193125-26-366931 · Items 8.01

  4. 4 · Ownership change

    Report date 2026-08-21 · 0001610717-26-000388

  5. 4 · Ownership change

    Report date 2026-08-21 · 0001610717-26-000387

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-335104

  7. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-335039 · Items 2.02,9.01

  8. 4 · Ownership change

    Report date 2026-06-29 · 0001610717-26-000311

  9. 4 · Ownership change

    Report date 2026-06-24 · 0001610717-26-000296

  10. 4 · Ownership change

    Report date 2026-06-18 · 0001610717-26-000290

  11. 4 · Ownership change

    Report date 2026-06-18 · 0001610717-26-000289

  12. 4 · Ownership change

    Report date 2026-06-18 · 0001610717-26-000287

  13. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-276718 · Items 5.02,5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-208969

  15. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-208918 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-18 · 0001193125-26-182453

  17. 8-K · Current report

    Report date 2026-04-14 · 0001193125-26-161800 · Items 1.01,2.03,8.01,9.01

  18. 8-K · Current report

    Report date 2026-04-14 · 0001193125-26-159289 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-13 · 0001193125-26-152039 · Items 8.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-071563

  21. 8-K · Current report

    Report date 2026-02-25 · 0001193125-26-071517 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266923

  23. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-266836 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-10-16 · 0001193125-25-241736 · Items 8.01

  25. 8-K · Current report

    Report date 2025-09-10 · 0001193125-25-200078 · Items 8.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104022

  27. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-103983 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-26 · 0001193125-25-151254 · Items 5.07

  29. 8-K · Current report

    Report date 2025-06-23 · 0001193125-25-145242 · Items 1.01,2.03,7.01,9.01

  30. 8-K · Current report

    Report date 2025-06-18 · 0001193125-25-142735 · Items 5.02

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-065660

  32. 8-K · Current report

    Report date 2025-05-07 · 0000950170-25-065618 · Items 2.02,9.01

  33. DEF 14A · Proxy statement

    Report date 2025-06-26 · 0001193125-25-103947

  34. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-027736

  35. 8-K · Current report

    Report date 2025-02-26 · 0000950170-25-027707 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-12-03 · 0001193125-24-271540 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2024-12-02 · 0001193125-24-268404 · Items 8.01

  38. SC 13G/A · Ownership disclosure

    0000902219-24-000477

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-122303

  40. 8-K · Current report

    Report date 2024-11-06 · 0000950170-24-122266 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 26 transaction rows26SGrant / award: 14 transaction rows14AExercise / conversion: 24 transaction rows24MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

64 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-24
2026-06-26
Anders JackS · Sale
Disposed
Common Stock5651.0169.24
2026-06-24
2026-06-26
Anders JackS · Sale
Disposed
Common Stock4553.0167.35
2026-06-24
2026-06-26
Anders JackS · Sale
Disposed
Common Stock9496.0168.2
2026-06-24
2026-06-26
Anders JackS · Sale
Disposed
Common Stock300.0170.32
2026-06-24
2026-06-26
Anders JackM · Exercise / conversion
Acquired
Common Stock20000.018.56
2026-06-24
2026-06-26
Anders JackM · Exercise / conversion
Acquired
Stock Option (Right to Buy)
Derivative security
20000.00.0
2026-06-18
2026-06-23
Kim Lorence H.A · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Kim Lorence H.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
Borisy AlexisA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Borisy AlexisA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
ANDERSON ELIZABETH MA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
ANDERSON ELIZABETH MA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
Horning SandraA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Horning SandraA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
Clyburn FrankA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Clyburn FrankA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
Patel SushilA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Patel SushilA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-18
2026-06-23
Borellini FlaviaA · Grant / award
Acquired
Common Stock1191.00.0
2026-06-18
2026-06-23
Borellini FlaviaA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3127.00.0
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock25725.026.5
2026-06-17
2026-06-17
Horn Margaret AS · Sale
Disposed
Common Stock29600.0160.12
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock3302.029.8
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock573.040.74
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
25725.00.0
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
573.00.0
2026-06-17
2026-06-17
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3302.00.0
2026-06-16
2026-06-18
Mancini AnthonyS · Sale
Disposed
Common Stock4615.0156.12
2026-06-16
2026-06-18
GOLDSMITH MARK AS · Sale
Disposed
Common Stock10020.0156.12
2026-06-16
2026-06-18
Cislini JeffS · Sale
Disposed
Common Stock2157.0156.12
2026-06-16
2026-06-18
Anders JackS · Sale
Disposed
Common Stock2722.0156.12
2026-06-16
2026-06-18
Kelsey Stephen MichaelS · Sale
Disposed
Common Stock4175.0156.12
2026-06-15
2026-06-17
Horn Margaret AS · Sale
Disposed
Common Stock60400.0160.17
2026-06-15
2026-06-17
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock44854.029.8
2026-06-15
2026-06-17
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock15546.040.74
2026-06-15
2026-06-17
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
15546.00.0
2026-06-15
2026-06-17
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
44854.00.0
2026-06-11
2026-06-15
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock8906.040.74
2026-06-11
2026-06-15
Horn Margaret AM · Exercise / conversion
Acquired
Common Stock1094.042.45
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock1315.0144.28
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock700.0146.04
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock885.0145.15
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock1800.0148.72
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock4600.0149.64
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock200.0150.17
2026-06-11
2026-06-15
Horn Margaret AS · Sale
Disposed
Common Stock500.0147.27
2026-06-11
2026-06-15
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
8906.00.0
2026-06-11
2026-06-15
Horn Margaret AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1094.00.0
2026-05-26
2026-05-28
Mancini AnthonyM · Exercise / conversion
Acquired
Common Stock3121.033.62
2026-05-26
2026-05-28
Mancini AnthonyS · Sale
Disposed
Common Stock700.0153.3

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001628171Revolution Medicines, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300JU3X0LBCQ65892
GLEIF legal name
REVOLUTION MEDICINES, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-08-12T14:58:24Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Revolution Medicines (United States) · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$11.58M$12.69M
2022-12-31$35.38M$40.36M
2021-12-31$29.39M$36.21M
2020-12-31$42.98M$55.46M
2019-12-31$50.04M$65.36M
2018-12-31$20.16M$26.81M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗